Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Interest & Investment Income of $158000.0 for Q3 2025, down 80.3% year-over-year from $802000.0 in Q3 2024, and down 40.15% quarter-over-quarter from $264000.0 in Q2 2025.
Vicarious Surgical (RBOT) Interest & Investment Income (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Interest & Investment Income for 6 consecutive years, with $158000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Interest & Investment Income fell 80.3% year-over-year to $158000.0; the TTM figure through Sep 2025 stood at $1.5 million (down 60.07% YoY), while the FY2024 annual figure was $3.3 million, down 25.74% from the prior year.
- Interest & Investment Income eased to $158000.0 in Q3 2025 per RBOT's latest filing, from $264000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.5 million in Q1 2023 and bottomed at -$1000.0 in Q3 2021.
- Historically, Interest & Investment Income has averaged $528473.7 across 5 years, with a median of $494000.0 in 2022.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 200.0% — and 2022, when it surged 49500.0%.
- Vicarious Surgical's Interest & Investment Income stood at $19000.0 in 2021, then surged by 4278.95% to $832000.0 in 2022, then advanced by 16.11% to $966000.0 in 2023, then tumbled by 38.51% to $594000.0 in 2024, then sank by 73.4% to $158000.0 in 2025.
- Business Quant data shows RBOT's Interest & Investment Income at $158000.0 in Q3 2025, $264000.0 in Q2 2025, and $446000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 446,000.00 |
| Dec 31, 2024 | 594,000.00 |
| Sep 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 918,000.00 |
| Mar 31, 2024 | 975,000.00 |
| Dec 31, 2023 | 966,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 832,000.00 |
| Sep 30, 2022 | 494,000.00 |
| Jun 30, 2022 | 101,000.00 |
| Mar 31, 2022 | 8,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -1,000.00 |